cdp 840 has been researched along with theophylline in 2 studies
*Theophylline: A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. [MeSH]
*Theophylline: A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP. [MeSH]
| Studies (cdp 840) | Trials (cdp 840) | Recent Studies (post-2010) (cdp 840) | Studies (theophylline) | Trials (theophylline) | Recent Studies (post-2010) (theophylline) |
|---|---|---|---|---|---|
| 18 | 0 | 3 | 20,076 | 1,612 | 1,383 |
| 17 | 1 | 0 | 20,076 | 1,612 | 1,383 |
| Protein | Taxonomy | cdp 840 (IC50) | theophylline (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Bos taurus (cattle) | 2.43 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jabaris, SS; Kodimuthali, A; Pal, M | 1 |
| Allen, JM; Banner, KH; Doherty, A; Jones, NA; Landells, LJ; O'Connor, BJ; Page, CP; Spina, D; Szilagy, CM | 1 |
1 review(s) available for cdp 840 and theophylline
| Article | Year |
|---|---|
Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease.
Topics: Asthma; Humans; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pulmonary Disease, Chronic Obstructive | 2008 |
1 other study(ies) available for cdp 840 and theophylline
| Article | Year |
|---|---|
Identification and quantification of phosphodiesterase 4 subtypes in CD4 and CD8 lymphocytes from healthy and asthmatic subjects.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adolescent; Adult; Allergens; Asthma; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Enzymologic; Humans; Isoenzymes; Leukocytes, Mononuclear; Male; Phosphodiesterase Inhibitors; Phytohemagglutinins; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA; Rolipram; Theophylline | 2001 |